PMC:6640909 / 36389-36558 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/6640909","sourcedb":"PMC","sourceid":"6640909","source_url":"https://www.ncbi.nlm.nih.gov/pmc/6640909","text":"Inhaled NO, epoprostenol (or prostacyclin) and phosphodiesterase 5 inhibitors may be considered to reduce right heart failure after LVAD implantation. IIb C [323–327]","divisions":[{"label":"td","span":{"begin":0,"end":150}},{"label":"td","span":{"begin":152,"end":155}},{"label":"td","span":{"begin":157,"end":158}}],"tracks":[{"project":"TEST0","denotations":[{"id":"31100109-9-16-7349","span":{"begin":165,"end":168},"obj":"[\"22727248\"]"}],"attributes":[{"subj":"31100109-9-16-7349","pred":"source","obj":"TEST0"}]},{"project":"MyTest","denotations":[{"id":"31100109-22727248-28905409","span":{"begin":165,"end":168},"obj":"22727248"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"attributes":[{"subj":"31100109-22727248-28905409","pred":"source","obj":"MyTest"}]},{"project":"0_colil","denotations":[{"id":"31100109-22727248-7349","span":{"begin":165,"end":168},"obj":"22727248"}],"attributes":[{"subj":"31100109-22727248-7349","pred":"source","obj":"0_colil"}]},{"project":"2_test","denotations":[{"id":"31100109-22727248-28905409","span":{"begin":165,"end":168},"obj":"22727248"}],"attributes":[{"subj":"31100109-22727248-28905409","pred":"source","obj":"2_test"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"TEST0","color":"#ec93b0","default":true},{"id":"MyTest","color":"#93caec"},{"id":"0_colil","color":"#e4ec93"},{"id":"2_test","color":"#da93ec"}]}]}}